Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Genet Mol Res ; 13(3): 7773-9, 2014 Sep 26.
Artigo em Inglês | MEDLINE | ID: mdl-25299091

RESUMO

The aim of this study was to investigate the correlation between apparent diffusion coefficients (ADCs), the relative apparent diffusion coefficient (rADC), and the pathological prognostic factor human epidermal growth factor receptor 2 (HER-2) in patients with breast cancer. A total of 64 women with breast cancer underwent breast diffusion-weighted imaging. HER-2 expression was detected in histological specimens. The ADC value, rADC value, and HER-2 level were determined. The ADC and rADC values of the breast cancer group were 1.1495 ± 0.1499 x 10(-3) and 0.6602 ± 0.0853, respectively. The differences in the ADC and rADC values between the two groups were statistically significant. There was no correlation between the ADC value and HER-2 expression in patients with breast cancer (r = -0.508, P = 0.043). However, the rADC value eliminated the individual differences to some extent. Therefore, compared to the ADC value, the rADC value had a better correlation with HER-2 expression.


Assuntos
Doenças Mamárias/diagnóstico , Neoplasias da Mama/diagnóstico , Imagem de Difusão por Ressonância Magnética/métodos , Adulto , Doenças Mamárias/metabolismo , Neoplasias da Mama/metabolismo , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Receptor ErbB-2/metabolismo
2.
AJNR Am J Neuroradiol ; 36(5): 855-60, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-25614477

RESUMO

BACKGROUND AND PURPOSE: The virtual noncontrast images generated with iodine subtraction from dual-energy CTA images are expected to replace the true noncontrast images for radiation-dose reduction. This study assessed the feasibility of virtual noncontrast images for diagnosing SAH. MATERIALS AND METHODS: Eighty-four patients with or without SAH underwent true noncontrast brain CT (the criterion standard for diagnosing SAH). Among them, 37 patients underwent an additional head dual-energy angiography, and the other patients underwent head and neck dual-energy angiography. Virtual noncontrast images were produced on a dedicated dual-energy postprocessing workstation and reconstructed in orientation and section width identical to those in true noncontrast images. The findings on the virtual noncontrast and true noncontrast images were compared at both the individual level and the lesion level. Image noise of the virtual noncontrast and true noncontrast images was also measured and compared. The volume CT dose index and dose-length product were recorded for the radiation-dose analysis. RESULTS: The sensitivity, specificity, positive predictive value, and negative predictive value of virtual noncontrast images at the individual level and the lesion level were 94.5%, 100%, 100%, 90.6% and 86.7%, 96.9%, 91.8%, 94.8%, respectively. The agreement in the diagnosis of SAH on true noncontrast and virtual noncontrast images reached 92.3% at the individual level and 85.1% at the lesion level. The virtual noncontrast images showed a higher image noise level. The volume CT dose index and dose-length product were obviously reduced without the true noncontrast brain CT scan. CONCLUSIONS: Virtual noncontrast images are a reliable tool for diagnosing SAH, with the advantage of reducing the radiation dose.


Assuntos
Angiografia Cerebral/métodos , Interpretação de Imagem Assistida por Computador/métodos , Hemorragia Subaracnóidea/diagnóstico por imagem , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X/métodos
3.
Hunan Yi Ke Da Xue Xue Bao ; 26(5): 469-72, 2001 Oct 28.
Artigo em Zh | MEDLINE | ID: mdl-12536506

RESUMO

OBJECTIVE: To determine the occurrence of activated protein C resistance (APCR), to identify APCR is associated with thrombotic events (TEs), and acquired APCR is associated with the presence of antiphospholipid antibodies (APLAs) in 30 patients with systemic lupus erythematosus (SLE). METHODS: Laboratory tests included dilute Russell's viper venom time assay for LA (dRVVT-LA), ELISA assay for ACL, APC sensitivity ratio, and factor V Leiden were detected by PCR-Mnl/I digestion. RESULTS: Acquired APCR was presented in 14(46.67%) of 30 patients. Factor V Leiden was not found in any patients. The incidence of TEs in the APCR-positive patients was significantly higher than that in the APCR-negative patients (42.85% vs 6.25%, P < 0.05). The incidence of TEs in the LA-positive patients was also significantly higher than that in the LA-negative patients (50% vs 11.1%, P < 0.05). CONCLUSIONS: The presence of either APCR or LAs is associated with one of the risk factors of TEs (P < 0.05). There is not a significant interaction between APCR and LAs in the association with TEs. Acquired APCR may not reflect the interference of LAs with the protein C pathway which may represent a mechanism of LA-associated TEs.


Assuntos
Resistência à Proteína C Ativada/imunologia , Anticorpos Antifosfolipídeos/sangue , Lúpus Eritematoso Sistêmico/imunologia , Resistência à Proteína C Ativada/complicações , Resistência à Proteína C Ativada/tratamento farmacológico , Adolescente , Adulto , Criança , Feminino , Humanos , Lúpus Eritematoso Sistêmico/complicações , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Masculino , Metilprednisolona/uso terapêutico , Pessoa de Meia-Idade , Fatores de Risco , Trombose Venosa/etiologia , Trombose Venosa/imunologia , Trombose Venosa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA